Skip to main content

Kathmere Capital Management, LLC

Source: SEC Form 13F · as of Mar 2026

Kathmere Capital Management, LLC holds 35 biotech & pharma companies tracked by BioSniper, totaling $72.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

35

Total value held

$72.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Globus Medical Inc. (GMED)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GMEDGlobus Medical Inc.271,126$23.4M
JNJJOHNSON & JOHNSON43,808$10.7M
LLYELI LILLY & Co4,463$4.1M
PMPhilip Morris International Inc24,796$4.1M
GILDGILEAD SCIENCES, INC.27,425$3.8M
MRKMerck & Co., Inc.28,957$3.5M
NVSNovartis AG21,586$3.3M
MCKMcKesson Corporation2,435$2.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)6,942$1.9M
PFEPFIZER INC53,348$1.5M
BMYBRISTOL MYERS SQUIBB CO23,174$1.4M
AMGNAMGEN INC3,982$1.4M
ABBVAbbVie Inc.6,244$1.4M
BIIBBIOGEN INC.6,643$1.2M
ZTSZoetis Inc.10,101$1.2M
AZNASTRAZENECA PLC5,687$1.1M
GMOptec International, Inc.12,637$941K
CAHCardinal Health Inc.4,242$896K
ABTABBOTT LABORATORIES7,644$785K
CORCencora Inc.1,862$585K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)9,280$512K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)15,932$295K
NVONovo Nordisk A/S7,965$293K
ELVElevance Health Inc.879$257K
SXTP60 DEGREES PHARMACEUTICALS, INC.144,683$253K
SNYSanofi5,250$253K
FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)9,690$219K
VRTXVERTEX PHARMACEUTICALS INC / MA489$218K
PBYIPUMA BIOTECHNOLOGY, INC.29,779$190K
AUPHAurinia Pharmaceuticals Inc.11,243$167K
BHCBausch Health Companies Inc.29,791$161K
INNVINNOVUS PHARMACEUTICALS, INC.15,534$125K
ARTLARTELO BIOSCIENCES, INC.13,250$100K
ORMPORAMED PHARMACEUTICALS INC.15,071$51K
BDTXBlack Diamond Therapeutics, Inc.13,813$29K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.